MIT researchers build implantable device that uses ultrasound to improve brain cancer drug delivery
The LUCID implant combines a drug reservoir with miniature ultrasound transducers to help chemotherapy drugs spread deeper into the brain
MIT researchers have designed an implantable drug-delivery device that uses ultrasound to help chemotherapy drugs spread farther through the brain, potentially improving treatment for the aggressive brain cancer glioblastoma. The device, called LUCID, can be implanted during tumour-removal surgery and wirelessly controlled to release drugs over an extended period while ultrasound enhances their distribution across the blood-brain barrier.